No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Raises Target Price to $16.5
Profound Medical (PRN) Receives a Buy From Lake Street
Profound Medical Unveils Q2 2024 Financials
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
Profound Medical Upgraded at Stifel on Medicare Policy Update
Profound Medical Shares Are Trading Higher After Stifel Upgraded the Stock From Hold to Buy.